Controversies in reproductive medicine: The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization

Journal of Assisted Reproduction and Genetics

Volumn 14, Issue 1, 1997, Pages 1-4

  Tarlatzis, Basil C ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LUTEINIZING HORMONE RELEASE; OOCYTE DEVELOPMENT; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0031036372     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02765740     Document Type: Article

References (22)

1. Tarlatzis BC, Grimbizis G: Assisted reproduction techniques in polycystic ovarian syndrome. Ann NY Acad Sci 1993;687:280-287
2. Meldrum DR: News and Views. J Assist Reprod Genet 1993;10:2-3
3. Baien AH, Tan SL, Jacobs HS: Hypersecretion of luteinizing hormone: A significant cause of infertility and miscarriage. Br J Obstet Gynaecol 1993;100:1082-1089
4. Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S: The prognostic value of basal luteinizing hormone: Follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques. Hum Reprod 1995;10:2545-2549
5. Homburg R, Feldberg D, Berkowitz D, Ashkenazi J, Levy T, Ben-Rafael Z: In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 1993;60:858-863
6. Homburg R, Feldberg D, Levy T, Ashkenazi J, Berkowitz D, Ben-Rafael Z, Farchi J: Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 1993;59:527-531
7. Turhan NO, Artini PG, D'Ambrogio G, Groghini F, Battaglia C, Genazzani AD, Volpe A, Genazzani AR: A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. J Assist Reprod Genet 1993;10:15-20
8. Owen JE, Davies MC, Kingsland CR, Jacobs HS, Mason BA: The use of a short regimen of buserelin, a gonadotropin-releasing hormone agonist and human menopausal gonadotropin in assisted conception cycles. Hum Reprod 1989;4:749-753
9. Schmutzler RK, Reichert C, Diedrich K, Wildt L, Diedrich Ch, Al-Hasani S, Van der Ven H, Krebs D: Combined GnRH-agonist/gonadotropin stimulation for in-vitro fertilization. Hum Reprod 1988;3 (Suppl 2):29-33
10. Dor J, Shulman A, Pariente C, Levran D, Bider D, Menashe Y, Mashiach S: The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: A prospective study. Fertil Steril 1992;57:366-371
11. Takahashi K, Eda Y, Abu-Musa A, Okada S, Yoshino K, Kitao M: Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome. Hum Reprod 1994;9:1231-1236
12. Lanzone A, Fulghesu AM, Spina MA, Apa R, Menini E, Caruso A, Mancuso A: Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987;65:1253-1258
13. Dor J, Shulman A, Levran D, Ben-Rafael Z, Rudak E, Mashiach S: The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. Hum Reprod 1990;5:816-818
14. Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal LH levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385-393
15. Howles CM, MacNamee MC, Edwards RG, Goswamy R, Steptoe PC: Effect of high tonic levels of luteinizing hormone on outcome of in vitro fertilization. Lancet 1986;2:521-523
16. Watson H, Kiddy DS, Hamilton-Fairley D, Scanlon MJ, Barnard C, Collins WP, Bonney RC, Franks S: Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod 1993;8:829-833
17. Hofmann GE, Bergh PA, Guzman I, Masuku S, Navot D: Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum Reprod 1993;8:695-698
18. Bider D, Levran D, Mashiach S, Ben-Shlomo I, Dor J: Polycystic ovarian disease (PCOD) - Pregnancy rate and outcome in in vitro fertilization. J Assist Reprod Genet 1993;10:11-14
19. Homburg R, Armar AN, Eshel A, Adams J, Jacobs HS: The influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in patients with polycystic ovary syndrome. Br Med J 1988;297:1024-1026
20. Hamilton-Fairley D, Kiddy D, Watson H, Sagle M, Franks S: Low dose gonadotropin therapy for induction of ovulation in 100 women with PCOS. Hum Reprod 1991;6:1095-1099
21. Johnson P, Pearce MJ: Recurrent spontaneous abortion and polycystic ovarian disease: Comparison of two regimens to induce ovulation. Br Med J 1990;300:154-156
22. Li TC, Serie E, Warren MA, Cooke ID: Is endometrial development in the periimplantation period influenced by high concentrations of luteinizing hormone in the follicular phase? Hum Reprod 1993;8:1021-1024